Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Remote Smartphone-based Monitoring of Parkinson’s Disease: A Real-world Multicenter Evaluation Across U.K. and U.S. Health Systems

Author:Muhammed, Kinan   Chmiel, Francis   Agley, Ledia   Hattar, Krystal   Tagliati, Michele   Frommel, Bridget   Phillips, Cheri   Rai, Shreya   Rodriguez, Diego   Laun, Olivia   Liu, Jennifer   Abou Chaar, Widad   Changizi, Barbara   El Kodsi, Daniel   Khurana, Vikram   Mason, Sheeba   Graham, Andrew   Clarke, Teresa   Rich, Rachel   Cosgrove, Jeremy   Butterworth, Stephen   Hulejczuk, Amanda   Burt, Mary   Heslop, Rebecca   Macerollo, Antonella   Ellis, Richard   Bromley, Joanne   Findlay, Nicola   Jenkins, Damian   Sarangmat, Nagaraja   Hu, Michele   

Session Name:S26: Movement Disorders: Clinical Trials and Therapeutics  

Topic:Movement Disorders  

Program Number:S26.002  

Author Institution:Kneu Health, London, United Kingdom  Cedars-Sinai Medical Center, Los Angeles, CA  Division of Movement disorders and American Parkinson’s Disease Association Center for Advanced Research, Brigham and Women’s Hospital, MA  East Suffolk and North Essex NHS Foundation Trust, United Kingdom  The Leeds Teaching Hospitals NHS Trust, United Kingdom  University Hospitals Sussex NHS Foundation Trust, United Kingdom  The Walton Centre NHS Foundation Trust, United Kingdom  The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom  Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom  University of Oxford, United Kingdom  

Exploratory Analyses from the Phase Three INDIGO Study Suggest Potential Mechanism of Seizure Control Through Tumor Volume Reduction Under Treatment With Vorasidenib

Author:Peters, Katherine   Mellinghoff, Ingo   Wick, Wolfgang   Van Den Bent, Martin   Blumenthal, Deborah   Touat, Mehdi   Clarke, Jennifer   Mendez, Joe   Welsh, Liam   Mason, Warren   Hottinger, Andreas   Sepulveda, Juan   Soffietti, Riccardo   Zhao, Dan   Yi, Denise   Weidl, Daniel   Steelman, Lori   Hassan, Islam   Wen, Patrick   Cloughesy, Timothy   

Session Name:S28: Neuro-oncology: Clinical and Practice Updates  

Topic:Neuro-oncology  

Program Number:S28.002  

Author Institution:Duke University Medical Center, Durham, NC  Memorial Sloan Kettering Cancer Center, New York, NY  Universitätsklinikum Heidelberg, Heidelberg & German Cancer Research Center, Heidelberg, Germany  Erasmus Medical Center, Rotterdam, Netherlands  Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel  Pitié Salpêtrière Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP) Sorbonne Université, Paris, France  UCSF, San Francisco, CA  Huntsman Cancer, Salt Lake City, UT  The Royal Marsden Hospital, London, United Kingdom  Toronto General Hospital, Toronto, ON, Canada  University Hospital of Lausanne, Lausanne, Switzerland  Hospital Universitario 12 de Octubre, Madrid, Spain  University of Turin, Torino, Italy  Servier Pharmaceuticals, CAMBRIDGE, MA  Servier Pharmaceuticals, Boston, MA  Servier Deutschland GmbH, Munich, Germany  Servier Pharmaceuticals, Wilmington, MA  Dana-Farber/Brigham and Women'S Cancer Center, Boston, MA  University of California Los Angeles, Los Angeles, CA  

[F-18]PBR06 TSPO-PET Reveals Region-specific Neuroinflammation in Multiple System Atrophy and Relates to Clinical Severity and Brain Atrophy

Author:Cicero, Steven   Rodriguez, Diego   Ndayisaba, Alain   Horan, Nicolas   Laun, Olivia   Pan, Hong   Rissanen, Eero   Dubey, Shipra   Young, Geoffrey   Kim, Jisoo   Willett, Ashlan   Pitaro, Ariana   Weiner, Howard   Khurana, Vikram   Singhal, Tarun   

Session Name:S33: Autonomic Disorders  

Topic:Autonomic Disorders  

Program Number:S33.002  

Author Institution:Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, Boston, MA  

Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding: Final Analyses of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO

Author:Dobson, Ruth   Bove, Riley   Hellwig, Kerstin   Oreja-Guevara, Celia   Derfuss, Tobias J.   Shah, Anna   Graham, Edith L.   McElrath, Thomas F.   Pietrasanta, Carlo   Maillart, Elisabeth   Jacobs, Dina   Kazlauskaite, Agne   Alves, Daniela   Raposo, Catarina   Craveiro, Licinio   Lin, Chien-Ju   Pasquarelli, Noemi   Vukusic, Sandra   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:S40.002  

Author Institution:Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK, London, United Kingdom  Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA, Berkeley, CA  Katholisches Klinikum Bochum, St. Josef Hospital, Universitätsklinikum, Bochum, Germany, Bochum, Germany  Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain, Madrid, Spain  University Hospital Basel, University of Basel, Basel, Switzerland, Basel, Switzerland  Rocky Mountain MS Center, Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA, Aurora, CO  Multiple Sclerosis and Neuroimmunology, Northwestern University, Chicago, IL, USA, Chicago, IL  Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA  NICU, Department of Woman, Child and Newborn, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, Milan, Italy  Neurology Department, Hôpital de la Pitié Salpêtrière, Assistance Publique des Hôpitaux de Paris, Paris, France, Paris, France  Department of Neurology, Perelman School of Medicine at the Hospital of the University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Service de Neurologie et Sclérose en Plaques, Fondation Eugène Devic EDMUS contre la Sclérose en Plaques, Hôpital Neurologique Pierre Wertheimer, Lyon, France, BRON Cedex, France  

Efficacy and Safety of Ocrelizumab Compared With Fingolimod in Pediatric-onset Relapsing-remitting MS: Results of the Phase III OPERETTA Two Study

Author:Banwell, Brenda   Kotulska, Katarzyna   Rostásy, Kevin   Deiva, Kumaran   Sato, Henry   Filippi, Massimo   Chitnis, Tanuja   Sormani, Maria Pia   Krupp, Lauren   Bar-Or, Amit   Evershed, Joanna   El Azzouzi, Bouchra   Wang, Qing   Lin, Chien-Ju   Hogea, Alexandra   Schneble, Hans-Martin   Manlius, Corinne   Waubant, Emmanuelle   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:S40.005  

Author Institution:Department of Pediatrics, Johns Hopkins University, Baltimore, MD, USA, Baltimore, MD  Department of Neurology and Epileptology, The Children’s Memorial Health Institute, Warsaw, Poland, Warsaw, Poland  Pediatric Neurology at Children's Hospital, Datteln, Germany, Datteln, Germany  Department of Pediatrics Neurology, Bicêtre Hospital, Le Kremlin-Bicêtre, France and Paris Sud-Saclay University, Le Kremlin-Bicêtre, France, Le Kremlin-Bicêtre, France  Neurological Institute of Curitiba, Curitiba, PR, Brazil, Curitiba, PR, Brazil  Neuroimaging Research Unit, Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy, Milan, Italy  Department of Pediatric Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA  DISSAL, University of Genoa, Genoa, Italy, Genoa, Italy  Department of Neurology, NYU Langone Health, New York, NY, USA, New York, NY  Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Neurology, University of California San Francisco, San Francisco, CA, USA, San Francisco, CA